R&D Strong solutions for increasing dermatology research diversi... As a woman of colour, I am very careful about the skin care products I use. I must be.
R&D Worrying signs for trial diversity require broad industry ac... A recent report found that diversity in clinical trials has dropped.
Views & Analysis Inclusive research and tackling health inequalities Health inequalities are a long-term condition and inclusive research is the only disease modifying therapy in the pipeline – but how can the community drive practical change?
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
